EPAS1 and melanoma: In this regard, we review the molecular mechanisms controlling the expression levels and specific functions of HIF-1α and HIF-2α and their downstream signalling elements during initiation and progression of leukaemias, glioblastoma multiforme, melanoma and epithelial cancers such as prostate, breast and pancreatic cancers.